37 results
Page 2 of 2
8-K
EX-99.1
bdvn7i95
11 Aug 20
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2020 Financial Results
4:05pm
424B4
qpnq 9jxm
8 Jul 20
Prospectus supplement with pricing info
4:35pm
8-K
EX-99.2
jdr cl6qlu
6 Jul 20
Our mission is to create a world without infectious disease
6:32am
DRS
gvos t0aaf4hccns
23 Jun 20
Draft registration statement
12:00am
10-K
m35wrrdwrk mka2j
26 Mar 20
Annual report
4:08pm
10-Q
giycqcphyjrogih7245
19 Nov 19
Quarterly report
4:06pm
424B4
xl95 i67u
11 Oct 19
Prospectus supplement with pricing info
5:31pm
S-1
EX-10.24
85dfl zlhozy8l
3 Sep 19
IPO registration
4:40pm
S-1
4edl9r2f
3 Sep 19
IPO registration
4:40pm
S-1
EX-10.17
vrfq4qqnjnj6y
3 Sep 19
IPO registration
4:40pm
DRS/A
EX-10.17
lv95gb
7 Aug 19
Draft registration statement (amended)
12:00am
DRS/A
4yjj9 2t13z8hhk
7 Aug 19
Draft registration statement (amended)
12:00am
DRS
tqajw38pjp5x42olf1t8
27 Jun 19
Draft registration statement
12:00am
DRS
EX-10.24
uw9wmiln9jkt69xk2
27 Jun 19
Draft registration statement
12:00am